Share-based Payment Arrangement, Expense of Core Scientific, Inc./tx from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Core Scientific, Inc./tx quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Core Scientific, Inc./tx Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $29,946,000, a 48% increase year-over-year.
  • Core Scientific, Inc./tx Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $94,503,000, a 109% increase year-over-year.
  • Core Scientific, Inc./tx annual Share-based Payment Arrangement, Expense for 2024 was $51,924,000, a 12% decline from 2023.
  • Core Scientific, Inc./tx annual Share-based Payment Arrangement, Expense for 2023 was $58,892,000, a 68% decline from 2022.
  • Core Scientific, Inc./tx annual Share-based Payment Arrangement, Expense for 2022 was $182,894,000, a 370% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Core Scientific, Inc./tx Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $94,503,000 $29,946,000 +$9,658,000 +48% 01 Jul 2025 30 Sep 2025 10-Q 24 Oct 2025 2025 Q3
Q2 2025 $84,845,000 $24,170,000 +$15,676,000 +185% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $69,169,000 $16,185,000 +$17,245,000 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $51,924,000 $24,202,000 +$6,724,000 +38% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $45,200,000 $20,288,000 +$5,427,000 +37% 01 Jul 2024 30 Sep 2024 10-Q 24 Oct 2025 2025 Q3
Q2 2024 $39,773,000 $8,494,000 -$5,786,000 -41% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 $45,559,000 $1,060,000 -$13,333,000 -109% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $58,892,000 $17,478,000 +$1,132,000 +6.9% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $57,760,000 $14,861,000 -$14,892,000 -50% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $72,652,000 $14,280,000 -$96,718,000 -87% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $169,370,000 $12,273,000 -$13,524,000 -52% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $182,894,000 $16,346,000 +$8,421,000 +106% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $174,473,000 $29,753,000 +$1,465,000 +5.2% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $173,008,000 $110,998,000 +$108,862,000 +5097% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023 2023 Q2
Q1 2022 $64,146,000 $25,797,000 +$25,209,000 +4287% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $38,937,000 $7,925,000 01 Oct 2021 31 Dec 2021 10-K 13 Mar 2024 2023 FY
Q3 2021 $28,288,000 01 Jul 2021 30 Sep 2021 10-Q 22 Nov 2022 2022 Q3
Q2 2021 $2,136,000 01 Apr 2021 30 Jun 2021 10-Q 22 Aug 2022 2022 Q2
Q1 2021 $588,000 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1

Core Scientific, Inc./tx Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $51,924,000 -$6,968,000 -12% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $58,892,000 -$124,002,000 -68% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $182,894,000 +$143,957,000 +370% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $38,937,000 +$35,899,000 +1182% 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2024 2023 FY
2020 $3,038,000 01 Jan 2020 31 Dec 2020 10-K 04 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.